Antiemetics Companies
Antiemetics are medications designed to prevent or alleviate nausea and vomiting. These drugs are commonly used in various medical conditions, including chemotherapy-induced nausea, postoperative nausea, and motion sickness.
Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
Latest Antiemetics Companies Update:
Evoke Pharma's Exclusivity: In April 2022, Evoke Pharma received three-year exclusivity for Gimoti (metoclopramide) nasal spray, providing them a competitive edge in the oral alternative drug segment.
Acacia Pharmaceutical's FDA Approval: Barhemsys, Acacia Pharmaceutical's antiemetic, received US-FDA approval in February 2022, expanding their product portfolio and addressing a niche market for nausea and vomiting associated with migraine.
Pfizer's Transdermal Patch Development: In September 2023, Pfizer partnered with Relief Therapeutics to develop a transdermal patch for Aprepitant (Emend), aiming to improve patient compliance and ease of administration for chemotherapy-induced nausea and vomiting.
Meda Pharmaceuticals' Expansion: Meda Pharmaceuticals acquired Australian pharmaceutical company, Almirall, in January 2023, strengthening their market presence in antiemetics with Almirall's innovative NKTR-105.
List of Antiemetics Key companies in the market
- GSK (UK)
- Merck (US)
- Sanofi-Aventis (France)
- Pfizer Inc. (US)
- Mylan (US)
- Eli Lilly and Company (US)
- Johnson & Johnson (US)
- Baxter International (US)
- Reddy's Laboratories Inc. (India)
Antiemetics Market Highlights:
Antiemetics Market Highlights:
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
